|
G |
ACO1 |
aconitase 1 |
decreases expression multiple interactions |
EXP |
lead nitrate results in decreased expression of ACO1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in decreased expression of ACO1 protein] |
CTD |
PMID:22502979 |
|
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
|
|
G |
ACTA1 |
actin alpha 1, skeletal muscle |
increases expression |
ISO |
lead nitrate results in increased expression of ACTA1 protein |
CTD |
PMID:20435106 |
|
NCBI chr 1:229,431,245...229,434,094
Ensembl chr 1:229,430,365...229,434,104
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions increases expression |
EXP |
AHR promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; AHR promotes the reaction [lead nitrate results in increased expression of TP53 mRNA] lead nitrate results in increased expression of AHR mRNA; lead nitrate results in increased expression of AHR protein |
CTD |
PMID:31682781 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AKAP3 |
A-kinase anchoring protein 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of AKAP3 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr12:4,615,518...4,649,051
Ensembl chr12:4,615,508...4,649,051
|
|
G |
ALAD |
aminolevulinate dehydratase |
multiple interactions decreases activity |
EXP |
lead nitrate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]] lead nitrate results in decreased activity of ALAD protein |
CTD |
PMID:2061546 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
decreases expression multiple interactions |
ISO |
lead nitrate results in decreased expression of APAF1 protein mangiferin inhibits the reaction [lead nitrate results in decreased expression of APAF1 protein] |
CTD |
PMID:23451106 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
|
|
G |
ARHGDIB |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
lead nitrate results in increased expression of ARHGDIB protein |
CTD |
PMID:20435106 |
|
NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728
|
|
G |
ARRDC5 |
arrestin domain containing 5 |
decreases expression |
ISO |
lead nitrate results in decreased expression of ARRDC5 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr19:4,890,437...4,916,820
Ensembl chr19:4,890,437...4,902,948
|
|
G |
AZIN2 |
antizyme inhibitor 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of AZIN2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:33,081,153...33,166,795
Ensembl chr 1:33,081,104...33,123,492
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
mangiferin inhibits the reaction [lead nitrate results in increased expression of BAX protein] [lead nitrate results in increased abundance of Lead] which results in increased expression of BAX mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of BAX mRNA]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of BAX mRNA] |
CTD |
PMID:23451106 PMID:30738203 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
lead nitrate results in decreased expression of BCL2 protein [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] |
CTD |
PMID:23451106 PMID:30738203 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
C1orf56 |
chromosome 1 open reading frame 56 |
decreases expression |
ISO |
lead nitrate results in decreased expression of C2H1ORF56 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:151,047,751...151,051,420
Ensembl chr 1:151,047,751...151,051,986
|
|
G |
CASP3 |
caspase 3 |
increases expression multiple interactions increases activity |
ISO EXP |
lead nitrate results in increased expression of CASP3 protein [lead nitrate results in increased abundance of Lead] which results in increased activity of CASP3 protein; [lead nitrate results in increased abundance of Lead] which results in increased expression of CASP3 mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP3 protein]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of CASP3 mRNA] puerarin inhibits the reaction [lead nitrate results in increased activity of CASP3 protein] mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP3 protein] |
CTD |
PMID:23451106 PMID:24505050 PMID:30738203 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
multiple interactions decreases expression |
ISO |
lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA] lead nitrate results in decreased expression of CASP7 mRNA |
CTD |
PMID:11891201 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases expression |
ISO EXP |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] [lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein; [lead nitrate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA] |
CTD |
PMID:23451106 PMID:30738203 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
decreases activity multiple interactions |
ISO EXP |
lead nitrate results in decreased activity of CAT protein [lead nitrate results in increased abundance of Lead] which results in decreased activity of CAT protein; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased activity of CAT protein] Ashwagandha inhibits the reaction [lead nitrate results in decreased activity of CAT protein]; puerarin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] mangiferin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] |
CTD |
PMID:23315276 PMID:23451106 PMID:24987671 PMID:30738203 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCNG1 |
cyclin G1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [CCNG1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199
|
|
G |
CD86 |
CD86 molecule |
increases expression |
ISO |
lead nitrate results in increased expression of CD86 protein |
CTD |
PMID:23376802 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CDYL |
chromodomain Y like |
decreases expression |
ISO |
lead nitrate results in decreased expression of CDYL mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:4,706,138...4,955,544
Ensembl chr 6:4,706,159...4,955,551
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
increases phosphorylation multiple interactions |
ISO |
lead nitrate results in increased phosphorylation of CHUK protein mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of CHUK protein] |
CTD |
PMID:23451106 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
COX8C |
cytochrome c oxidase subunit 8C |
decreases expression |
ISO |
lead nitrate results in decreased expression of COX8C mRNA |
CTD |
PMID:21628963 |
|
NCBI chr14:93,347,182...93,348,356
Ensembl chr14:93,347,182...93,348,356
|
|
G |
CRISP2 |
cysteine rich secretory protein 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of CRISP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:49,676,652...49,714,220
Ensembl chr 6:49,692,358...49,713,590
|
|
G |
CRYAA |
crystallin alpha A |
affects metabolic processing |
ISO |
lead nitrate affects the metabolism of CRYAA protein |
CTD |
PMID:21139692 |
|
NCBI chr21:43,169,008...43,172,810
Ensembl chr21:43,169,008...43,172,810
|
|
G |
CRYAB |
crystallin alpha B |
affects metabolic processing |
ISO |
lead nitrate affects the metabolism of CRYAB protein |
CTD |
PMID:21139692 |
|
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
|
|
G |
CST8 |
cystatin 8 |
decreases expression |
ISO |
lead nitrate results in decreased expression of CST8 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr20:23,491,117...23,507,124
Ensembl chr20:23,491,101...23,496,010
|
|
G |
CTNNA1 |
catenin alpha 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [CTNNA1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
ISO EXP |
[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein; [lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA] lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of CTNNB1 mRNA] |
CTD |
PMID:30731080 PMID:35738543 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CUX2 |
cut like homeobox 2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,034,165...111,350,554
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression |
EXP |
lead nitrate results in increased expression of CXCL8 protein |
CTD |
PMID:34189835 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions increases expression |
EXP ISO |
lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(k)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; lead nitrate promotes the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA] lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA] lead nitrate results in increased expression of CYP1A1 mRNA; lead nitrate results in increased expression of CYP1A1 protein |
CTD |
PMID:8902619 PMID:11162773 PMID:11408366 PMID:17889500 PMID:23391631 PMID:31682781 More...
|
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
decreases activity multiple interactions |
EXP ISO |
lead nitrate results in decreased activity of CYP1A2 protein lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein]; lead nitrate results in decreased expression of and results in decreased activity of CYP1A2 protein |
CTD |
PMID:8902619 PMID:11162773 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP2C18 |
cytochrome P450 family 2 subfamily C member 18 |
increases expression |
ISO |
lead nitrate results in increased expression of CYP2C11 mRNA |
CTD |
PMID:23391631 |
|
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
|
|
G |
CYP4A22 |
cytochrome P450 family 4 subfamily A member 22 |
increases expression |
ISO |
lead nitrate results in increased expression of CYP4A1 mRNA |
CTD |
PMID:23391631 |
|
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
|
|
G |
CYP51A1 |
cytochrome P450 family 51 subfamily A member 1 |
increases expression multiple interactions |
ISO |
lead nitrate results in increased expression of CYP51 mRNA [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA] |
CTD |
PMID:15475176 PMID:22293356 |
|
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression multiple interactions |
ISO |
lead nitrate results in decreased expression of CYP7A1 mRNA [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA] |
CTD |
PMID:15475176 PMID:16049268 PMID:22293356 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
lead nitrate results in increased expression of DDIT3 mRNA |
CTD |
PMID:14971657 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
multiple interactions |
ISO |
[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA; [lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein] |
CTD |
PMID:30731080 |
|
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
|
|
G |
DMP1 |
dentin matrix acidic phosphoprotein 1 |
multiple interactions |
EXP |
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of DMP1 mRNA] |
CTD |
PMID:35738543 |
|
NCBI chr 4:87,650,280...87,664,357
Ensembl chr 4:87,650,280...87,664,361
|
|
G |
DNASE1 |
deoxyribonuclease 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [DNASE1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:3,611,760...3,665,461
Ensembl chr16:3,611,728...3,680,143
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions decreases expression |
EXP |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA] lead nitrate results in decreased expression of DNMT3A mRNA; lead nitrate results in decreased expression of DNMT3A protein |
CTD |
PMID:24639330 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DSPP |
dentin sialophosphoprotein |
multiple interactions |
EXP |
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of DSPP mRNA] |
CTD |
PMID:35738543 |
|
NCBI chr 4:87,608,529...87,616,873
Ensembl chr 4:87,608,529...87,616,873
|
|
G |
E2F1 |
E2F transcription factor 1 |
multiple interactions |
EXP |
E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; lead nitrate inhibits the reaction [E2F1 protein results in decreased expression of PTGS2 mRNA] |
CTD |
PMID:24639330 |
|
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
|
|
G |
EGFL8 |
EGF like domain multiple 8 |
increases expression |
ISO |
lead nitrate results in increased expression of EGFL8 protein |
CTD |
PMID:19332663 |
|
NCBI chr 6:32,164,595...32,168,281
Ensembl chr 6:32,164,595...32,168,281
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions increases phosphorylation |
EXP |
EGFR mutant form affects the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; EGFR mutant form affects the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; EGFR mutant form affects the reaction [lead nitrate results in increased secretion of Dinoprostone]; EGFR promotes the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of EGFR protein] |
CTD |
PMID:20850495 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EIF2AK1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
increases response to substance multiple interactions |
ISO |
EIF2AK1 gene mutant form results in increased susceptibility to lead nitrate [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased abundance of Bilirubin; [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased abundance of Malondialdehyde; [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased expression of HAMP mRNA |
CTD |
PMID:25411909 |
|
NCBI chr 7:6,022,247...6,059,175
Ensembl chr 7:6,022,247...6,059,175
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases phosphorylation multiple interactions |
ISO |
lead nitrate results in increased phosphorylation of EIF4EBP1 protein puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:27762461 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
ERCC1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
multiple interactions |
ISO |
lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
|
|
G |
ERCC3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
multiple interactions |
ISO |
lead nitrate affects the reaction [ERCC3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:127,257,290...127,294,144
Ensembl chr 2:127,257,290...127,294,166
|
|
G |
EZR |
ezrin |
multiple interactions |
ISO |
lead nitrate affects the reaction [EZR affects the expression of MT1 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
|
|
G |
FABP9 |
fatty acid binding protein 9 |
decreases expression |
ISO |
lead nitrate results in decreased expression of FABP9 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 8:81,458,253...81,461,579
Ensembl chr 8:81,458,253...81,461,579
|
|
G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
increases expression |
ISO |
lead nitrate results in increased expression of FDFT1 mRNA |
CTD |
PMID:15475176 |
|
NCBI chr 8:11,795,582...11,839,298
Ensembl chr 8:11,795,573...11,839,395
|
|
G |
FDPS |
farnesyl diphosphate synthase |
increases expression |
ISO |
lead nitrate results in increased expression of FDPS mRNA |
CTD |
PMID:15475176 |
|
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
|
|
G |
FHL1 |
four and a half LIM domains 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of FHL1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
lead nitrate results in increased expression of FOS mRNA |
CTD |
PMID:14971657 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FOXA2 |
forkhead box A2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [FOXA2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455
|
|
G |
FTL |
ferritin light chain |
increases expression |
ISO |
lead nitrate results in increased expression of FTL protein |
CTD |
PMID:19332663 |
|
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
decreases activity |
ISO |
lead nitrate results in decreased activity of G6PD protein |
CTD |
PMID:28557068 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
lead nitrate results in increased expression of GADD45A mRNA |
CTD |
PMID:14971657 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GARIN1B |
golgi associated RAB2 interactor 1B |
decreases expression |
ISO |
lead nitrate results in decreased expression of GARIN1B mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 7:128,709,061...128,731,743
Ensembl chr 7:128,709,061...128,731,743
|
|
G |
GFAP |
glial fibrillary acidic protein |
multiple interactions increases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP protein] lead nitrate results in increased expression of GFAP mRNA; lead nitrate results in increased expression of GFAP protein |
CTD |
PMID:24987671 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GGNBP1 |
gametogenetin binding protein 1 (pseudogene) |
decreases expression |
ISO |
lead nitrate results in decreased expression of GGNBP1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:33,583,699...33,589,026
Ensembl chr 6:33,583,699...33,589,026
|
|
G |
GH1 |
growth hormone 1 |
multiple interactions decreases secretion |
ISO |
lead nitrate inhibits the reaction [GHRH protein results in increased expression of GH1 protein] lead nitrate results in decreased secretion of GH1 protein |
CTD |
PMID:12022635 |
|
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
|
|
G |
GHRH |
growth hormone releasing hormone |
multiple interactions |
ISO |
lead nitrate inhibits the reaction [GHRH protein results in increased expression of GH1 protein] |
CTD |
PMID:12022635 |
|
NCBI chr20:37,251,086...37,261,814
Ensembl chr20:37,251,086...37,261,819
|
|
G |
GJA5 |
gap junction protein alpha 5 |
multiple interactions increases expression |
ISO |
lead nitrate affects the reaction [GJA5 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT2 mRNA] lead nitrate results in increased expression of GJA5 mRNA |
CTD |
PMID:11891201 |
|
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
|
|
G |
GJB2 |
gap junction protein beta 2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [GJB2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
|
|
G |
GRIN2A |
glutamate ionotropic receptor NMDA type subunit 2A |
multiple interactions |
ISO |
lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,183,337
|
|
G |
GRIN2C |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
ISO |
lead nitrate results in increased expression of GRIN2C mRNA |
CTD |
PMID:23358146 |
|
NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504
|
|
G |
GSG1 |
germ cell associated 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of GSG1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr12:13,083,532...13,103,667
Ensembl chr12:13,083,532...13,103,683
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
[lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:30731080 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions decreases activity |
ISO |
mangiferin inhibits the reaction [lead nitrate results in decreased activity of GSR protein] |
CTD |
PMID:23451106 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
multiple interactions decreases expression |
EXP |
AHR promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; RELA promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; Resveratrol inhibits the reaction [lead nitrate results in decreased expression of GSTA1 mRNA] |
CTD |
PMID:31682781 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTT1 |
glutathione S-transferase theta 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [GSTT1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
multiple interactions |
ISO |
[lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased expression of HAMP mRNA |
CTD |
PMID:25411909 |
|
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
|
|
G |
HMGB4 |
high mobility group box 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of HMGB4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:33,860,475...33,864,791
Ensembl chr 1:33,860,475...33,864,791
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression multiple interactions |
ISO |
lead nitrate results in increased expression of HMGCR mRNA [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA] |
CTD |
PMID:15475176 PMID:16705668 PMID:22293356 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
ISO EXP |
lead nitrate results in increased expression of HMOX1 mRNA |
CTD |
PMID:23391631 PMID:34189835 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression |
ISO |
lead nitrate results in decreased expression of HNF4A mRNA |
CTD |
PMID:16049268 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HSP90AB1 |
heat shock protein 90 alpha family class B member 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
|
|
G |
HSPA2 |
heat shock protein family A (Hsp70) member 2 |
multiple interactions decreases expression increases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA2 mRNA] lead nitrate results in decreased expression of HSPA2 mRNA |
CTD |
PMID:21628963 PMID:24987671 |
|
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO EXP |
lead nitrate results in increased expression of HSPA5 protein lead nitrate results in increased expression of HSPA5 mRNA |
CTD |
PMID:14971657 PMID:20435106 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA9 |
heat shock protein family A (Hsp70) member 9 |
multiple interactions increases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 protein] lead nitrate results in increased expression of HSPA9 mRNA; lead nitrate results in increased expression of HSPA9 protein |
CTD |
PMID:24987671 |
|
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
|
|
G |
IGF2 |
insulin like growth factor 2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [IGF2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
|
|
G |
IGFBP6 |
insulin like growth factor binding protein 6 |
multiple interactions |
ISO |
lead nitrate affects the reaction [IGFBP6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions increases expression |
ISO |
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] results in decreased susceptibility to lead nitrate lead nitrate results in increased expression of IL1A mRNA |
CTD |
PMID:22293356 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] results in decreased susceptibility to lead nitrate lead nitrate results in increased expression of IL1B mRNA lead nitrate results in increased expression of IL1B mRNA; lead nitrate results in increased expression of IL1B protein |
CTD |
PMID:15475176 PMID:16049268 PMID:22293356 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
decreases secretion |
EXP |
lead nitrate results in decreased secretion of IL2 protein |
CTD |
PMID:27714827 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL6R |
interleukin 6 receptor |
multiple interactions |
ISO |
lead nitrate affects the reaction [IL6RA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
[lead nitrate results in increased abundance of Lead] inhibits the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:33038468 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
IQCF1 |
IQ motif containing F1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of IQCF1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 3:51,894,876...51,903,353
Ensembl chr 3:51,894,876...51,903,353
|
|
G |
IQCF5 |
IQ motif containing F5 |
decreases expression |
ISO |
lead nitrate results in decreased expression of IQCF5 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 3:51,873,721...51,875,601
Ensembl chr 3:51,873,721...51,875,601
|
|
G |
ITGA6 |
integrin subunit alpha 6 |
multiple interactions |
ISO |
lead nitrate affects the reaction [ITGA6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:172,427,336...172,506,459
Ensembl chr 2:172,234,216...172,506,459
|
|
G |
ITGAM |
integrin subunit alpha M |
multiple interactions |
ISO |
lead nitrate affects the reaction [ITGAM affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
|
|
G |
KRT14 |
keratin 14 |
increases expression |
ISO |
lead nitrate results in increased expression of KRT14 protein |
CTD |
PMID:20435106 |
|
NCBI chr17:41,582,279...41,586,895
Ensembl chr17:41,582,279...41,586,895
|
|
G |
LAMP1 |
lysosomal associated membrane protein 1 |
increases expression |
ISO |
lead nitrate results in increased expression of LAMP1 protein |
CTD |
PMID:23376802 |
|
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
|
|
G |
LAMP2 |
lysosomal associated membrane protein 2 |
increases expression |
ISO |
lead nitrate results in increased expression of LAMP2 protein |
CTD |
PMID:23376802 |
|
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
|
|
G |
LDHC |
lactate dehydrogenase C |
decreases expression |
ISO |
lead nitrate results in decreased expression of LDHC mRNA |
CTD |
PMID:21628963 |
|
NCBI chr11:18,412,318...18,452,063
Ensembl chr11:18,412,318...18,452,063
|
|
G |
LRRC46 |
leucine rich repeat containing 46 |
decreases expression |
ISO |
lead nitrate results in decreased expression of LRRC46 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:47,831,670...47,837,719
Ensembl chr17:47,831,634...47,837,719
|
|
G |
LTA |
lymphotoxin alpha |
multiple interactions |
ISO |
lead nitrate affects the reaction [LTA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
|
|
G |
LYPD4 |
LY6/PLAUR domain containing 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of LYPD4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr19:41,835,075...41,844,871
Ensembl chr19:41,837,074...41,844,697
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:20850495 PMID:22502979 PMID:23451106 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:20850495 PMID:22502979 PMID:23451106 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MARCHF11 |
membrane associated ring-CH-type finger 11 |
decreases expression |
ISO |
lead nitrate results in decreased expression of MARCHF11 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 5:16,067,139...16,179,791
Ensembl chr 5:16,067,139...16,180,762
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions |
ISO |
lead nitrate affects the reaction [MCL1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MET |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions |
ISO |
lead nitrate affects the reaction [MET affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
|
|
G |
MGST1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [MGST1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
|
|
G |
MIR139 |
microRNA 139 |
increases expression |
EXP |
lead nitrate results in increased expression of MIR139 mRNA |
CTD |
PMID:35738543 |
|
NCBI chr11:72,615,063...72,615,130
Ensembl chr11:72,615,063...72,615,130
|
|
G |
MIR142 |
microRNA 142 |
increases expression |
EXP |
lead nitrate results in increased expression of MIR142 mRNA |
CTD |
PMID:35738543 |
|
NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318
|
|
G |
MROH2B |
maestro heat like repeat family member 2B |
decreases expression |
ISO |
lead nitrate results in decreased expression of MROH2B mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 5:40,998,020...41,071,342
Ensembl chr 5:40,998,017...41,071,342
|
|
G |
MT-CO1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions decreases expression |
ISO |
puerarin inhibits the reaction [lead nitrate results in decreased expression of COX1 mRNA] |
CTD |
PMID:23315276 |
|
NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
|
|
G |
MT-CO2 |
mitochondrially encoded cytochrome c oxidase II |
multiple interactions decreases expression |
ISO |
puerarin inhibits the reaction [lead nitrate results in decreased expression of COX2 mRNA] |
CTD |
PMID:23315276 |
|
NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
|
|
G |
MT-CO3 |
mitochondrially encoded cytochrome c oxidase III |
multiple interactions decreases expression |
ISO |
puerarin inhibits the reaction [lead nitrate results in decreased expression of COX3 mRNA] |
CTD |
PMID:23315276 |
|
NCBI chr MT:9,207...9,990
Ensembl chr MT:9,207...9,990
|
|
G |
MT1X |
metallothionein 1X |
increases expression multiple interactions decreases response to substance affects localization |
ISO |
lead nitrate results in increased expression of MT1 mRNA lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT1 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT1 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RAD23 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT1 mRNA]; MT1 protein promotes the reaction [lead nitrate results in increased expression of SNCA mRNA] MT1 results in decreased susceptibility to lead nitrate lead nitrate affects the localization of MT1 protein |
CTD |
PMID:11891201 PMID:19542206 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions decreases response to substance |
ISO |
lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT2 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT2 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT2 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT2 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT2 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RAD23 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT2 mRNA] MT2 results in decreased susceptibility to lead nitrate |
CTD |
PMID:11891201 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
increases phosphorylation multiple interactions |
ISO |
lead nitrate results in increased phosphorylation of MTOR protein puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of MTOR protein] |
CTD |
PMID:27762461 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
lead nitrate affects the reaction [MYC affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYH6 |
myosin heavy chain 6 |
decreases expression |
ISO |
lead nitrate results in decreased expression of MYH6 protein |
CTD |
PMID:23391631 |
|
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
|
|
G |
MYH7 |
myosin heavy chain 7 |
increases expression multiple interactions |
ISO |
lead nitrate results in increased expression of MYH7 mRNA; lead nitrate results in increased expression of MYH7 protein resveratrol inhibits the reaction [lead nitrate results in increased expression of MYH7 mRNA] |
CTD |
PMID:23391631 |
|
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
|
|
G |
NCAM1 |
neural cell adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in decreased expression of NCAM1 mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in decreased expression of NCAM1 protein] lead nitrate results in decreased expression of NCAM1 mRNA; lead nitrate results in decreased expression of NCAM1 protein |
CTD |
PMID:24987671 |
|
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
decreases expression multiple interactions |
ISO |
lead nitrate results in decreased expression of NFKBIA protein mangiferin inhibits the reaction [lead nitrate results in decreased expression of NFKBIA protein] |
CTD |
PMID:23451106 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFKBIB |
NFKB inhibitor beta |
multiple interactions |
ISO |
lead nitrate affects the reaction [NFKBIB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
|
|
G |
NPPB |
natriuretic peptide B |
increases expression |
ISO |
lead nitrate results in increased expression of NPPB mRNA |
CTD |
PMID:23391631 |
|
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
lead nitrate results in increased expression of NQO1 mRNA |
CTD |
PMID:23391631 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of NR0B2 mRNA |
CTD |
PMID:15475176 PMID:16049268 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of NR1H3 mRNA |
CTD |
PMID:15475176 |
|
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
|
|
G |
NR5A2 |
nuclear receptor subfamily 5 group A member 2 |
increases expression |
ISO |
lead nitrate results in increased expression of NR5A2 mRNA |
CTD |
PMID:16049268 |
|
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
|
|
G |
NUMB |
NUMB endocytic adaptor protein |
multiple interactions |
ISO |
lead nitrate affects the reaction [NUMB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr14:73,275,216...73,458,546
Ensembl chr14:73,275,107...73,466,167
|
|
G |
ODF1 |
outer dense fiber of sperm tails 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of ODF1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 8:102,551,589...102,561,018
Ensembl chr 8:102,551,589...102,561,018
|
|
G |
PAQR5 |
progestin and adipoQ receptor family member 5 |
decreases expression |
ISO |
lead nitrate results in decreased expression of PAQR5 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr15:69,298,912...69,407,780
Ensembl chr15:69,298,912...69,407,780
|
|
G |
PIAS2 |
protein inhibitor of activated STAT 2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [PIAS2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr18:46,803,218...46,920,145
Ensembl chr18:46,803,218...46,920,160
|
|
G |
PLA2G4A |
phospholipase A2 group IVA |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; 2-aminoethoxydiphenyl borate inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; [lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone; EGFR mutant form affects the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; EGFR mutant form affects the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; EGFR promotes the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA] |
CTD |
PMID:20850495 |
|
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
|
|
G |
POLD1 |
DNA polymerase delta 1, catalytic subunit |
multiple interactions |
ISO |
lead nitrate affects the reaction [POLD1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr19:50,384,323...50,418,018
Ensembl chr19:50,384,204...50,418,018
|
|
G |
POU3F3 |
POU class 3 homeobox 3 |
multiple interactions |
ISO |
lead nitrate affects the reaction [POU3F3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:104,854,115...104,858,574
Ensembl chr 2:104,853,287...104,858,574
|
|
G |
PRM1 |
protamine 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of PRM1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:11,280,841...11,281,330
Ensembl chr16:11,280,841...11,281,330
|
|
G |
PRM3 |
protamine 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of PRM3 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:11,273,199...11,273,629
Ensembl chr16:11,273,199...11,273,629
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PTGS2 protein]; [lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone; Decitabine promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; lead nitrate inhibits the reaction [E2F1 protein results in decreased expression of PTGS2 mRNA]; lead nitrate promotes the reaction [RB1 protein results in increased expression of PTGS2 mRNA]; RB1 protein promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PTGS2 protein] lead nitrate results in increased expression of PTGS2 mRNA; lead nitrate results in increased expression of PTGS2 protein |
CTD |
PMID:20850495 PMID:21435385 PMID:24639330 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
multiple interactions increases expression |
EXP |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of RB1 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of RB1 protein]; lead nitrate promotes the reaction [RB1 protein results in increased expression of PTGS2 mRNA]; RB1 protein promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of RB1 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of RB1 protein] |
CTD |
PMID:24639330 |
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RBL2 |
RB transcriptional corepressor like 2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [RBL2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
ISO EXP |
mangiferin inhibits the reaction [lead nitrate results in increased expression of RELA protein] lead nitrate results in increased expression of RELA mRNA; lead nitrate results in increased expression of RELA protein RELA promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; RELA promotes the reaction [lead nitrate results in increased expression of TP53 mRNA] |
CTD |
PMID:23451106 PMID:31682781 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RIBC2 |
RIB43A domain with coiled-coils 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of RIBC2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr22:45,413,693...45,432,509
Ensembl chr22:45,413,693...45,432,509
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation multiple interactions |
ISO |
lead nitrate results in increased phosphorylation of RPS6KB1 protein puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:27762461 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RUNX1 |
RUNX family transcription factor 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [RUNX1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO EXP |
[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA; [lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein] lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of RUNX2 mRNA] |
CTD |
PMID:30731080 PMID:35738543 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SMCP |
sperm mitochondria associated cysteine rich protein |
decreases expression |
ISO |
lead nitrate results in decreased expression of SMCP mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:152,878,322...152,885,047
Ensembl chr 1:152,878,322...152,885,047
|
|
G |
SNCA |
synuclein alpha |
affects localization multiple interactions increases expression |
ISO |
lead nitrate affects the localization of SNCA protein MT1 protein promotes the reaction [lead nitrate results in increased expression of SNCA mRNA] |
CTD |
PMID:19542206 |
|
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
|
|
G |
SOCS1 |
suppressor of cytokine signaling 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [SOCS1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions decreases activity |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in decreased activity of SOD1 protein] |
CTD |
PMID:24987671 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SP3 |
Sp3 transcription factor |
multiple interactions decreases expression |
ISO |
lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA] lead nitrate results in decreased expression of SP3 mRNA |
CTD |
PMID:11891201 |
|
NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373
|
|
G |
SPATA18 |
spermatogenesis associated 18 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA18 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:52,051,304...52,097,299
Ensembl chr 4:52,051,304...52,097,299
|
|
G |
SPATA20 |
spermatogenesis associated 20 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA20 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:50,547,174...50,555,852
Ensembl chr17:50,543,058...50,555,852
|
|
G |
SPATA21 |
spermatogenesis associated 21 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA21 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:16,395,677...16,437,842
Ensembl chr 1:16,387,117...16,437,424
|
|
G |
SPATA6 |
spermatogenesis associated 6 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA6 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:48,261,389...48,472,204
Ensembl chr 1:48,295,373...48,472,208
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions increases expression |
ISO |
lead nitrate affects the reaction [SQSTM1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT2 mRNA] puerarin inhibits the reaction [lead nitrate results in increased expression of SQSTM1 protein] |
CTD |
PMID:11891201 PMID:27762461 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SREBF2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
ISO |
lead nitrate results in increased expression of SREBF2 mRNA |
CTD |
PMID:15475176 PMID:16705668 |
|
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
|
|
G |
SUMO1 |
small ubiquitin like modifier 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [SUMO1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:202,206,171...202,238,597
Ensembl chr 2:202,206,182...202,238,599
|
|
G |
TBX2 |
T-box transcription factor 2 |
multiple interactions |
ISO |
lead nitrate affects the reaction [TBX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466
|
|
G |
TEKT2 |
tektin 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TEKT2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:36,084,094...36,088,275
Ensembl chr 1:36,084,094...36,088,275
|
|
G |
TEKT4 |
tektin 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TEKT4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 2:94,871,430...94,876,823
Ensembl chr 2:94,871,430...94,876,823
|
|
G |
TMOD1 |
tropomodulin 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TMOD1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 9:97,501,180...97,601,743
Ensembl chr 9:97,501,180...97,601,743
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA] Lead nitrate increases expression of Tnf mRNA in liver |
CTD RGD |
PMID:15475176 PMID:16049268 PMID:22293356 PMID:9049203 |
RGD:14995487 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
lead nitrate affects the reaction [TNFRSF1A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
multiple interactions |
ISO |
lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
|
|
G |
TNP1 |
transition protein 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TNP1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 2:216,859,458...216,860,064
Ensembl chr 2:216,859,458...216,860,064
|
|
G |
TNP2 |
transition protein 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TNP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:11,267,857...11,269,325
Ensembl chr16:11,267,748...11,269,533
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases expression |
EXP |
[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA; AHR promotes the reaction [lead nitrate results in increased expression of TP53 mRNA]; RELA promotes the reaction [lead nitrate results in increased expression of TP53 mRNA]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA] |
CTD |
PMID:30738203 PMID:31682781 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TPPP2 |
tubulin polymerization promoting protein family member 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TPPP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr14:21,024,299...21,036,352
Ensembl chr14:21,024,109...21,036,276
|
|
G |
TRIM27 |
tripartite motif containing 27 |
multiple interactions |
ISO |
lead nitrate affects the reaction [TRIM27 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:28,903,002...28,923,985
Ensembl chr 6:28,903,002...28,923,988
|
|
G |
TRPM2 |
transient receptor potential cation channel subfamily M member 2 |
multiple interactions |
EXP |
lead nitrate inhibits the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein] |
CTD |
PMID:22750002 |
|
NCBI chr21:44,353,621...44,442,644
Ensembl chr21:44,350,163...44,443,081
|
|
G |
TSC22D3 |
TSC22 domain family member 3 |
multiple interactions |
ISO |
[lead nitrate results in increased abundance of Lead] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:29957541 |
|
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
|
|
G |
TSG101 |
tumor susceptibility 101 |
multiple interactions |
ISO |
lead nitrate affects the reaction [TSG101 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr11:18,480,311...18,526,942
Ensembl chr11:18,468,336...18,526,951
|
|
G |
TSSK2 |
testis specific serine kinase 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TSSK2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr22:19,131,308...19,132,622
Ensembl chr22:19,131,308...19,132,622
|
|
G |
TSSK3 |
testis specific serine kinase 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TSSK3 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:32,362,539...32,364,312
Ensembl chr 1:32,351,521...32,364,312
|
|
G |
TTF1 |
transcription termination factor 1 |
multiple interactions |
ISO |
lead nitrate affects the reaction [TTF1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 9:132,375,548...132,406,840
Ensembl chr 9:132,375,548...132,406,851
|
|
G |
TUBA8 |
tubulin alpha 8 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TUBA8 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr22:18,110,809...18,131,732
Ensembl chr22:18,110,100...18,146,683
|
|
G |
TULP2 |
TUB like protein 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TULP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr19:48,880,967...48,898,744
Ensembl chr19:48,880,965...48,898,744
|
|
G |
WNT1 |
Wnt family member 1 |
multiple interactions |
EXP |
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of WNT1 mRNA] |
CTD |
PMID:35738543 |
|
NCBI chr12:48,978,322...48,982,620
Ensembl chr12:48,978,322...48,982,620
|
|
G |
WNT3A |
Wnt family member 3A |
multiple interactions |
ISO |
[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA; [lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein] |
CTD |
PMID:30731080 |
|
NCBI chr 1:228,006,998...228,061,271
Ensembl chr 1:228,006,998...228,061,271
|
|
G |
WNT4 |
Wnt family member 4 |
multiple interactions |
ISO |
lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 1:22,117,313...22,143,097
Ensembl chr 1:22,117,313...22,143,969
|
|
G |
ZFHX3 |
zinc finger homeobox 3 |
multiple interactions |
ISO |
lead nitrate affects the reaction [ZFHX3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:72,782,885...73,891,930
Ensembl chr16:72,782,885...73,891,871
|
|
G |
ZNRF4 |
zinc and ring finger 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of ZNRF4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr19:5,455,417...5,456,856
Ensembl chr19:5,455,417...5,456,856
|
|